SIGN UP FOR UPDATES!
Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
ENGLEMED
Contact Englemed
Our contact email address.
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
BOOKS AND GIFTS THIS WAY!
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here
SEARCH THIS SITE
Google

WWW Englemed
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
FreeDigitalPhotos
www.freedigitalphotos.net
FreeWebPhotos
www.freewebphoto.com
FROM OUR NEWS FEEDS
Elite football players 'more likely to develop dementia'
Fri March 17th - Elite male footballers are more likely to develop dementia than the general population, according to a Swedish study published today. More
RECENT COMMENTS
On 09/10/2020 William Haworth wrote:
How long is recovery time after proceedure... on Ablation cuts atrial fibrillat...
On 08/02/2018 David Kelly wrote:
Would you like to write a piece about this to be i... on Researchers unveil new pain re...
On 23/10/2017 Cristina Pereira wrote:
https://epidemicj17.imascientist.org.uk/2017/06/21... on HIV breakthrough - MRC...
On 12/09/2017 Aparna srikantam wrote:
Brilliant finding! indeed a break through in under... on Leprosy research breakthrough...
On 01/07/2017 Annetta wrote:
I have been diagnosed with COPD for over 12 years.... on Seaweed plan for antimicrobial...
OTHER NEWS FEEDS OF INTEREST
ENGLEMED HEALTH NEWS

Inflammation heart disease puzzle

Thursday February 26th, 2015

Chronic inflammation is usually thought to be unhealthy - but now researchers, using new genetic techniques, say it may sometimes protect against heart disease.

The Cambridge University study sheds new light on potential side-effects of powerful drugs now used to treat conditions such as arthritis.

The research centred on one key cause of inflammation, the substance interleukin-1. Some drugs are designed to combat the problem by controlling interleukin-1.

The findings come from genetic studies of more than a million people, including some who have naturally occurring limits on interleukin-1, placing them at low risk of getting arthritis.

But, it emerged, they had a 15% increased risk of developing coronary heart disease and a tendency to increased levels of unhealthy low density lipoprotein cholesterol.

There was also an increased risk of developing abdominal aortic aneurysm.

The findings were reported today in the Lancet Diabetes and Endocrinology.

Researcher Dr Daniel Freitag said: "The common view is that inflammation promotes the development of heart disease - we've shown that the truth is clearly more complicated.

" We need to be careful that drugs like anakinra that aim to tackle rheumatoid arthritis by inhibiting interleukin-1 do not have unintended consequences on an individual's risk of heart disease."

The medical director of the British Heart Foundation Professor Peter Weissberg said the study did not yet show side-effects from the drug.

He said: "It is important to remember that this is not a study of an anti-arthritis drug but a gene that can mimic its effects.

"The effects of a gene are lifelong, whereas a drug only affects a person while it is being taken."

The Interleukin-1 Genetics Consortium. Cardiometabolic consequences of genetic up-regulation of the interleukin-1 receptor antagonist: Mendelian randomisation analysis. Lancet Diabetes and Endocrinology 6 February, 2015.

Tags: Genetics | Heart Health | Pharmaceuticals | Rheumatology | UK News

Printer friendly page Printer friendly page

CATEGORIES